Skip to Content

Article

Navigating ECG Cardiac Safety Requirements

JAY MASON

Dr. Jay W Mason

Chief Medical Officer

CASSANDRA ERATO

Cassandra Erato

CEO

To prevent the risk of induced arrhythmias in cardiac drug development, it is important for developers and biotech companies to adhere to ECG safety requirements in early stage research.

Download

 

This article was published in International Clinical Trials May 2020, pages 56-60. © Samedan Ltd.

Back to Resources

Ready to partner with Spaulding Clinical for your Phase I study?

Let’s Talk